batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASH 2024 – GSK's Blenrep Dreamm gets better 10 December 2024 ASH 2024 – full steam ahead for arlo-cel 10 December 2024 ASH 2024 – Affimed plays up AFM28's safety, despite one death 9 December 2024 Keytruda/Lynparza link-up disappoints again 9 December 2024 Merck RORs into phase 3 6 December 2024 Merus bags its first approval 5 December 2024 Ipsen finds a MAIT in Biomunex 4 December 2024 Takeda grabs Keros’s Geron challenger 3 December 2024 Load More